Nojiri Masafumi, Abe Ryudai, Nagae Sumito, Tanaka Takuya, Takahara Yutaka
Respiratory Medicine, Kanazawa Medical University, Ishikawa, JPN.
Cureus. 2024 Oct 18;16(10):e71777. doi: 10.7759/cureus.71777. eCollection 2024 Oct.
Adenocarcinoma with ROS1 rearrangement is rare. Carcinomatous pericarditis is generally seen in advanced stages and is a life-threatening condition. A 21-year-old male was admitted to our hospital because of severe dyspnea due to cardiac tamponade identified on echocardiography. A diagnosis of ROS1-rearranged adenocarcinoma of the lung was made from the pathological and gene mutation analyses of the cell block from his pericardial fluid. Oral administration of entrectinib was highly effective, and his serum carcinoembryonic antigen (CEA) level improved from 247 to 10.8 ng/mL. The present case has clinical significance because a pathological and genetic diagnosis was made from the pericardial effusion fluid, and the clinical manifestations of cardiac tamponade due to lung cancer were well controlled by the administration of entrectinib.
伴有ROS1重排的腺癌较为罕见。癌性心包炎通常见于晚期,是一种危及生命的疾病。一名21岁男性因超声心动图检查发现心脏压塞导致严重呼吸困难而入住我院。通过对其心包积液细胞块的病理和基因突变分析,诊断为肺ROS1重排腺癌。口服恩曲替尼疗效显著,其血清癌胚抗原(CEA)水平从247 ng/mL降至10.8 ng/mL。本病例具有临床意义,因为通过心包积液进行了病理和基因诊断,且肺癌所致心脏压塞的临床表现通过恩曲替尼治疗得到了良好控制。